Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study
Ayoub Mokhtari(Université Libre de Bruxelles), Maria Antonietta Bali(Royal Marsden NHS Foundation Trust), Thomas Guiot(Université Libre de Bruxelles), Zohaib Salahuddin(Maastricht University), Philippe Lambin(Maastricht University Medical Centre), Alain Hendlisz(London Cancer), Zelda Paquier(Université Libre de Bruxelles), Henry C. Woodruff(Maastricht University Medical Centre), Roberto Casale(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Jean‐Luc Van Laethem(Deventer Ziekenhuis)
Cited by 3
Related Papers
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
|The Lancet Oncology|2014|727
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
|Journal of Crohn s and Colitis|2013|669